RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Total assets

Edwards Lifesciences CorpEW

Market cap
$49.9B
P/E ratio
SummaryFinancials
Period EndTotal assets (Million USD)YoY (%)
Dec 31, 202413,055+39.43%
Dec 31, 20239,363+12.91%
Dec 31, 20228,293-2.47%
Dec 31, 20218,503+17.49%
Dec 31, 20207,237+11.54%
Dec 31, 20196,488+21.87%
Dec 31, 20185,324-6.53%
Dec 31, 20175,696+26.29%
Dec 31, 20164,510+11.10%
Dec 31, 20154,059+15.18%
Dec 31, 20143,524+29.35%
Dec 31, 20132,725+22.65%
Dec 31, 20122,222+12.17%
Dec 31, 20111,981+12.07%
Dec 31, 20101,767

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)